Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases

Nurlubek Katkenov1, Zhussipbek Mukhatayev1, Samat Kozhakhmetov1

  • 1Laboratory of Microbiome, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.

Insights

Chronic inflammation drives cardiovascular diseases (CVDs). This review shows elevated Interleukin-6 (IL-6) and Interleukin-1β (IL-1β) significantly increase adverse cardiovascular events, suggesting targeted therapies.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Inflammation Research

Background:

  • Cardiovascular diseases (CVDs) are a primary global health burden, strongly linked to chronic inflammatory processes.
  • Key inflammatory cytokines, Interleukin-6 (IL-6) and Interleukin-1β (IL-1β), are critically involved in the pathogenesis and progression of CVDs.

Purpose of the Study:

  • To systematically review and synthesize evidence on the roles of IL-6 and IL-1β in cardiovascular diseases.
  • To evaluate the impact of these cytokines on cardiovascular outcomes and explore potential therapeutic targets.

Main Methods:

  • A comprehensive literature search was performed in PubMed and Embase for studies published between January 2014 and December 2024.
  • Included studies investigated IL-6 and/or IL-1β in CVDs across human and animal models, focusing on clinical outcomes, mechanisms, or therapies.
  • Data extraction and quality assessment were conducted by two independent reviewers, with meta-analyses performed where appropriate.

Main Results:

  • The review analyzed 12 studies, revealing significant associations between elevated IL-6 and conditions like peripheral artery disease, myocardial infarction, and heart failure.
  • Higher IL-1β levels were correlated with poorer outcomes in coronary artery disease and heart failure.
  • Meta-analyses confirmed a significant link between increased IL-6 and IL-1β levels and a higher risk of adverse cardiovascular events.

Conclusions:

  • Elevated levels of IL-6 and IL-1β are strongly associated with increased risk and severity of cardiovascular diseases.
  • Targeting IL-6 and IL-1β presents a promising therapeutic avenue for mitigating inflammation and improving cardiovascular health outcomes.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
29
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
967
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
2.7K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
592